Redpoint Bio Corporation (OTC BB: RPBC), a leading biotechnology company, is focused on developing better tasting products for the pharmaceutical, food and beverage industries. The recent progression in taste biology has produced a number of new approaches to the discovery and development of innovative taste blockers and enhancers. The company leverages its modern tools of biotechnology to discover revolutionary ways to make medicines more palatable and enhance the taste of prepared foods and beverages. For further information, visit the Company’s web site at www.redpointbio.com.
- 16 years ago
QualityStocks
Redpoint Bio Corporation (OTC BB: RPBC)
Tags Rodman & Renshaw
Related Post
-
D-Wave Quantum Inc. (NYSE: QBTS) Expands Quantum Optimization Offerings to Accelerate Commercial Adoption
At its Qubits 2025 user conference, D-Wave introduced new hybrid solver capabilities supporting continuous variables…
-
Soligenix Inc. (NASDAQ: SNGX) Advances CiVax Amid Ongoing COVID-19 Threat
An increase in deaths from COVID-19 underscores the persistent danger of the virus and the…
-
Thumzup Media Corp. (NASDAQ: TZUP) Continues Building Its Client Base with Its Proprietary Tech for Ad Campaigns
Social media commerce is expected to grow to $821 billion in 2025[1], demonstrating its importance…